KURN — Kuros Biosciences AG Share News
0.000.00%
- CH₣828.53m
- CH₣831.76m
- $146.06m
Brief: Kuros Announces Terms Of Proposed Capital Increase
Brief: Kuros Biosciences Convenes Extraordinary General Meeting
Brief: Kuros Biosciences Announces Full Commercial Launch Of Magnetos
Brief: Kuros Biosciences Announces U.S. FDA Approval Of IND Application
Brief: Kuros Biosciences H1 Net Loss At CHF 5.2 Million
Brief: Kuros Biosciences Signs Agreement With Surgical Specialties
Brief: Kuros Biosciences To Propose Re-Appointment Of Chairman And Board Members
Brief: Kuros Biosciences Enters Convertible Bond Financing Agreement For Up To CHF 5 Mln
Brief: Kuros Biosciences Gets US Marketing Clearance For Intervertebral Body Fusion Device
Brief: Kuros Biosciences Wins Order For Bone Graft Supply For U.S. Seaspine
Brief: Kuros Biosciences Signs Agreement To Supply Seaspine With Bone Graft Incorporating Kuros's Advanced Submicron Surface Technology
Brief: Kuros Biosciences Completes Capital Increase
Swiss stocks - Factors to watch on Dec. 14
Brief: Kuros Announces Final Result Of Capital Increase
Brief: Kuros To Implement Capital Increase
Swiss stocks - Factors to watch on Dec. 13
Brief: Kuros Biosciences Receives FDA Clearance For Extending Commercial Indications Of Magnetos Putty
Brief: Kuros Biosciences Receives FDA 510(K) Clearance
Brief: Kuros Biosciences To Propose Ordinary Share Capital Increase Of Up To CHF 4.3 Mln